Retatrutide 20mg
Code: RT20 · Category: Metabolic & Weight Management · Price: ₹10,000
Summary
Triple-receptor agonist peptide (GIP / GLP-1 / Glucagon) — 20 mg lyophilized, ≥98% HPLC purity.
Full description
Retatrutide 20 mg is a higher-concentration format of the triple-agonist peptide Retatrutide. Each vial contains 20 mg of lyophilized peptide for research applications requiring larger working stock.
Research Profile
- Triple-agonist activity across GIP, GLP-1, and glucagon receptors
- Studied in metabolic, energy-balance, and glucose-handling research models
- Larger vial format for high-throughput studies
- QC verified by HPLC and mass spectrometry
Specifications
- Compound: Retatrutide (LY3437943)
- Dosage: 20 mg per vial
- Purity: ≥ 98% (HPLC)
- Form: Lyophilized powder
- Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
Specifications
| Compound | Retatrutide (LY3437943) |
|---|---|
| Class | Triple-agonist peptide (GIP / GLP-1 / Glucagon receptor) |
| Dosage | 20 mg per vial |
| Purity | ≥ 98% (HPLC) |
| Form | Lyophilized powder |
| Appearance | White to off-white cake |
| Storage | Store lyophilized at 2–8 °C. Reconstituted: –20 °C, use within 30 days. |
| Reconstitution | Bacteriostatic water (sold separately) |
| Research Use | Investigational compound for laboratory research only. |